About us


Dr. Enej Kuščer: CEO, Director for business development. With scientific background in pharmaceutical biotechnology and extensive managerial and financial experience, Dr. Kuščer oversees the financial and business activities of the company.

Dr. Stefan Fujs: CEO, Technical director. As a leading expert in microbiology, fermentation and bioprocess development, Dr. Fujs directs the operations and laboratory activities of the company.

Dr. Gregor Kosec: Head of science and IP. A chemist and biochemist by training, Dr. Kosec has had many years of experience in molecular biology of industrial microorganisms and secondary metabolites and has worked with some of the leading pharmaceutical companies on development projects.

ABCloneTM is fast and efficient solution for cloning of large natural and synthetic DNA fragments. We provide ABCloneTM as a stand alone service for getting quickly your long DNA fragment sub-cloned into plasmid vector of your choice.

More >>
Acies Bio received the “Jesenko Award” from Biotechnical Faculty of University of Ljubljana. The award recognizes institutions for their outstanding research work in the field of biotechnology.

Within H2020 SME Innovation Associate project we invite a “Disease Model Development Manager” to join our team.

More >>
European Medicines Agency (EMA) granted orphan medicinal product designation to its lead compound CAB1803 for Pantothenate-kinase-associated neurodegeneration (PKAN)

More >>
Scientists at ACIES BIO made a breakthrough innovation: high-value technology that uses unique and economic bioprocess to convert acid waste whey from dairy factories into high value animal feed products (vitamin B12) and clean water in the same process. Check out Whey2Value!

More >>